YPSOMED HOLDING AGYPSOMED HOLDING AGYPSOMED HOLDING AG

YPSOMED HOLDING AG

No trades
See on Supercharts

OWX fundamentals

An in-depth look to YPSOMED HOLDING AG operating, investing, and financing activities

OWX free cash flow for H1 24 is -31.64 M CHF. For 2023, OWX free cash flow was 46.85 M CHF and operating cash flow was 163.22 M CHF.

‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
TTM
Free cash flowYoY growth